🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Mitigating Chronic Respiratory Disease Through the Lens of Multi-Morbidity

Recruitingn/aAges 30 Years - anyAllUniversity College, London
NCT07050823 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The investigators aim to make it easier to find people with undiagnosed long-term lung health problems (such as asthma, and chronic obstructive pulmonary disease, COPD, collectively called 'Chronic Respiratory Diseases', CRDs) living in Brasil. Because people with undiagnosed CRDs often have other medical problems too, such as heart problems, high blood pressure and diabetes (collectively called 'Long Term Conditions', LTC), the investigators will look for undiagnosed CRD in people with LTC when they are attending appointments at local health centres in the cities of Sao Carlos and Sao Paulo. To look for undiagnosed CRDs the investigators will use two questionnaire-based methods called 'COLA' and 'SBQ'. These are quick and simple to do. All participants will also have tests of their lung function completed including spirometry and Fractional Exhaled Nitric Oxide so that the investigato

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Attending primary health care services in Brasil. Diagnosed with one or more existing, non-respiratory long-term conditions such as cardiovascular disease, diabetes or hypertension. Exclusion Criteria: Clinically unstable in the past month (defined as worsening symptoms requiring emergency care or hospitalization). Current pregnancy. Active pulmonary tuberculosis or undergoing treatment for pulmonary tuberculosis. Current acute respiratory infection. Cognitive impairment that prevents understanding of the case-finding questionnaire, defined as MMSE score ≤20. Contraindications to spirometry. Declines to participate in the study.
💊

What it tests

  • Not listed
📍

Where

2 sites
Multiple primary care sites
São Carlos, Brazil
Multiple primary care sites
São Paulo, Brazil
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy